Questions & answers. What is Symbyax, the new drug being marketed for the treatment of bipolar depression.
Miller
Michael Craig
MC
D000928:Antidepressive Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D004338:Drug Combinations; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans
D000928:Antidepressive Agents; D004338:Drug Combinations; C492572:olanzapine-fluoxetine combination; D005473:Fluoxetine; D001569:Benzodiazepines